CO2 Solutions Inc. Announces Unaudited Consolidated Financial Results for the Third Quarter and Nine Months Ended March 31, 2017
CO2 Solutions Inc. announced unaudited consolidated financial results for the third quarter and nine months ended March 31, 2017. The Corporation recorded revenues for the three-month period and the nine-month period ended March 31, 2017 of $0.05 million related to the sale of carbonic anhydrase enzyme to a third party for use in CO2 capture for enhancing the growth of algae for economical, sustainable production of protein and biofuel products. The Corporation recorded a loss of $0.90 million or $0.01 per share, for the three-month period ended March 31, 2017, an increase of $0.25 million from the loss of $0.66 million, or $0.00 per share, for the same period in 2016.
For the nine-month period ended March 31, 2017, the Corporation recorded a loss of $3.65 million or $0.03 per share, a small increase of $0.02 million from the loss of $3.64 million, or $0.03 per share, for the same period in 2016.